摘要
目的分析急性心肌梗死(AMI)并发左心室附壁血栓(LvT)行经皮冠脉介入治疗(PCI)患者的临床特征及抗栓治疗。方法收集煤炭总医院2005年8月至2012年2月确诊为急性心肌梗死并发左室附壁血栓并行PCI治疗的12例患者的临床资料,对其进行回顾性分析。结果广泛前壁心肌梗死、前壁心肌梗死9例(75%),左室射血分数低于40%共7例(58%),冠脉造影检查三支及以上血管病变7例(58%)。6例给予华法林、阿司匹林、氯吡格雷三联抗栓,2例给予西洛他唑、阿司匹林及氯吡格雷三联抗血小板治疗,随访期间血栓均消失。4例双联抗血小板治疗者l例发生脑梗死后加用华法林,3例患者血栓消失,1例血栓机化。12例患者均未出现严重出血现象。结论急性心肌梗死并发左心室附壁血栓并接受PCI治疗患者,充分衡量获益及出血风险,按照个体化原则给予抗栓治疗安全有效。
Objective To analyze the clinical characteristics and anticoagulation therapy of post-PCI pa- tients with left ventricular mural thrombus (LVT) after acute myocardial infarction (AMI). Methods The clinical data of 12 post-PCI patients with LVT after AMI enrolled from August 2005 to February 2012 were retrospectively analyzed. Results The anterior AM1 was 9(75%). Patients with LVEF〈40% was 7(58%). Coronary angiography showed 7 patients(58%) with 3 branches coronary lesions. 6 patients were given warfarin, aspirin and clopidogrel, 2 were given cilostazol, aspirin and clopidogrel, the LVT was disappeared during follow-up period. 4 patients were given aspirin and clopidogrel, in which 1 has cerebral infarction and then added warfarin, LVT disappeared in 3 cases and 1 thrombus was found to be organization. No serious bleeding complications happened in 12 patients. Conclusion For post-PCI patients with LVT after AMI, after assessing the beneficiation and risk of bleeding, the anticoagulation therapy with individual principle is safe and favorable.
出处
《中国心血管病研究》
CAS
2012年第8期576-579,共4页
Chinese Journal of Cardiovascular Research
关键词
急性心肌梗死
左心室附壁血栓
抗凝治疗
经皮冠状动脉介入治疗
Acute myocardial infarction
Left ventricular mural thrombus
Anticoagulation
Percutaneous coronary intervention